Article
Candidate-gene criteria for clinical reporting: diagnostic exome sequencing identifies altered candidate genes among 8% of patients with undiagnosed diseases.
Genetics in medicine : official journal of the American College of Medical Genetics - 1 Feb 2017
Farwell Hagman Kelly D, Shinde Deepali N, Mroske Cameron, Smith Erica, Radtke Kelly, Shahmirzadi Layla, El-Khechen Dima, Powis Zöe, Chao Elizabeth C, Alcaraz Wendy A, Helbig Katherine L, Sajan Samin A, Rossi Mari, Lu Hsiao-Mei, Huether Robert, Li Shuwei, Wu Sitao, Nuñes Mark E, Tang Sha
Abstract excerpt
PURPOSE: Diagnostic exome sequencing (DES) is now a commonly ordered test for individuals with undiagnosed genetic disorders. In addition to providing a diagnosis for characterized diseases, exome sequencing has the capacity to uncover novel candidate genes for disease. METHODS: Family-based DES included analysis of both characterized and novel genetic etiologies. To evaluate candidate genes for disease in the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
